Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

ChristianaCare

Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

32nd Annual Update in Cardiology

Overview

The annual Update in Cardiology will be held via Zoom videoconferencing on March 6, 2021.

The nationally recognized faculty will address controversial issues, sustained paradigms and practical issues across the broad spectrum of cardiology.

Date/Time

Saturday, March 6, 2021 (7 a.m.–2 p.m.)
Location: Virtual Conference
Register now. Registration deadline is March 4, 2021.

Target Audience

This symposium is designed to give primary care physicians and cardiologists practical updates in recent advances in cardiovascular diagnosis and treatment.

Learner Objectives

The nationally recognized faculty will address controversial issues, sustained paradigms and practical issues across the broad spectrum of cardiology.

Registration

Registration fees are:

  • $35 for physicians
  • $15 for retired physicians
  • Residents, fellows, nursing students and medical students are at no cost.

For more information, email the Office of Continuing Medical Education or call 302-623-3882.

Agenda

     
7 a.m.   Virtual Vendor Hall and Break-Out Rooms Open
     
7:50 a.m.   Welcome
     
8 a.m.   Keynote: Cardiac Complications of COVID-19
  Sahil Parikh, M.D.
Columbia University
New York, NY
9 a.m.   Cardiovascular Genetics: Cardiomyopathy and Aortopathies
Pawel Pomianowski, M.D.
ChristianaCare
Newark, DE
   
9:25 a.m.   Interpretation of High Sensitivity Troponin
Chad J. Zack, M.D., MS, FACC
Penn State Heart and Vascular Institute, PennState Health
Hershey, PA
9:50 a.m.   Aortic Valve Disease for the Non-Cardiologist
Steven Assalita, M.D.
ChristianaCare Cardiology Consultants
Newark, DE
10:15 a.m.   Mitral Valve Disease for the Non-Cardiologist
Erin Fender, M.D., MS, FACC
Program Chair
Cardiologist, ChristianaCare Cardiology Consultants
Newark, DE
10:35 a.m.   Acute and Chronic Management of Pulmonary Embolism
Vladimir Lakhter, D.O.
Assistant Professor, Medicine, Temple Heart and Vascular Institute
Temple University Hospital
Philadelphia, PA
10:55 a.m.   Heart Disease in Women
Patricia J. M. Best, M.D.
Mayo Clinic
Rochester, MN
11:20 a.m.   Aortic Valve Disease for the Non-Cardiologist
Ali Hamid, M.D.
Cardiologist, ChristianaCare Cardiology Consultants
Newark, DE
11:45 a.m.   Break and Vendor Break-Out Rooms
12:15 p.m.   Mitral Valve Disease for the Non-Cardiologist
Niya Jones, M.D., MPH
ChristianaCare
Newark, DE
12:40 p.m.   Wearable Cardiac Technologies
Henry Weiner, M.D., FACC
Medical Director, ChristianaCare Cardiology Consultants
Associate Chief for Quality & Safety, ChristianaCare
Newark, DE
1:05 p.m.   Closing Remarks and Vendor Break-Out Rooms Open

CE Contact Hours

CME credits and ABIM MOC points are anticipated.

Register now.